HCC
LLY icon

Hirtle Callaghan & Co’s Eli Lilly LLY Stock Holding History

Hirtle Callaghan & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-98
Closed -$7K – 212
2014
Q4 		$7K Sell
98
-2
-2% -$135 ﹤0.01% 451
2014
Q3 		$6K Hold
100
– – ﹤0.01% 498
2014
Q2 		$6K Hold
100
– – ﹤0.01% 534
2014
Q1 		$6K Sell
100
-1,135
-92% -$63.3K ﹤0.01% 519
2013
Q4 		$63K Hold
1,235
– – 0.01% 307
2013
Q3 		$62K Buy
1,235
+100
+9% +$5.24K 0.01% 319
2013
Q2 		$56K Buy
+1,135
New +$61.8K 0.65% 32

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hirtle Callaghan & Co's LLY Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Eli Lilly (LLY) in Q1 2015, closing a stake of 98 shares — an estimated $7K sold.

Hirtle Callaghan & Co first reported a position in LLY in Q2 2013 and held it in 7 quarters. The position peaked at $63K in Q4 2013. 1,116 funds tracked by Wall St. Rank hold LLY as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Eli Lilly position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 98 Eli Lilly shares in Q1 2015, an estimated $7K.
  • Hirtle Callaghan & Co first reported a position in Eli Lilly in Q2 2013 and held it in 7 quarters.
  • Hirtle Callaghan & Co's Eli Lilly position peaked at $63K in Q4 2013.
  • 1,116 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.